New England Research & Management, Inc. Organon & Co. Transaction History

New England Research & Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$18.65 - $23.03 $14,024 - $17,318	-752 Reduced 4.46%	16,092 $308,000
Q2 2024 Jul 09, 2024	SELL	$17.45 - $21.96 $24,866 - $31,293	-1,425 Reduced 7.8%	16,844 $349,000
Q1 2024 Apr 16, 2024	SELL	$13.78 - $18.8 $3,472 - $4,737	-252 Reduced 1.36%	18,269 $343,000
Q4 2023 Feb 06, 2024	SELL	$10.95 - $17.32 $4,434 - $7,014	-405 Reduced 2.14%	18,521 $267,000
Q3 2023 Oct 10, 2023	SELL	$16.59 - $23.77 $49,770 - $71,310	-3,000 Reduced 13.68%	18,926 $329,000
Q2 2023 Jul 05, 2023	SELL	$19.27 - $24.63 $2,408 - $3,078	-125 Reduced 0.57%	21,926 $456,000
Q1 2023 Apr 06, 2023	SELL	$21.42 - $32.08 $267,278 - $400,294	-12,478 Reduced 36.14%	22,051 $519,000
Q4 2022 Jan 09, 2023	BUY	$23.31 - $28.61 $344,988 - $423,428	14,800 Added 75.02%	34,529 $964,000
Q3 2022 Oct 06, 2022	BUY	$23.4 - $34.25 $461,658 - $675,718	19,729 New	19,729 $462,000

794

202M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.03B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.